Cancer, Viruses, and Mass Migration: Paul Berg's Venture into Eukaryotic Biology and the Advent of Recombinant DNA Research and Technology, 1967-1980

Journal of the History of Biology 41 (4):589 - 636 (2008)
Abstract The existing literature on the development of recombinant DNA technology and genetic engineering tends to focus on Stanley Cohen and Herbert Boyer's recombinant DNA cloning technology and its commercialization starting in the mid-1970s. Historians of science, however, have pointedly noted that experimental procedures for making recombinant DNA molecules were initially developed by Stanford biochemist Paul Berg and his colleagues, Peter Lobban and A. Dale Kaiser in the early 1970s. This paper, recognizing the uneasy disjuncture between scientific authorship and legal invention in the history of recombinant DNA technology, investigates the development of recombinant DNA technology in its full scientific context. I do so by focusing on Stanford biochemist Berg's research on the genetic regulation of higher organisms. As I hope to demonstrate, Berg's new venture reflected a mass migration of biomedical researchers as they shifted from studying prokaryotic organisms like bacteria to studying eukaryotic organisms like mammalian and human cells. It was out of this boundary crossing from prokaryotic to eukaryotic systems through virus model systems that recombinant DNA technology and other significant new research techniques and agendas emerged. Indeed, in their attempt to reconstitute 'life' as a research technology, Stanford biochemists' recombinant DNA research recast genes as a sequence that could be rewritten thorough biochemical operations. The last part of this paper shifts focus from recombinant DNA technology's academic origins to its transformation into a genetic engineering technology by examining the wide range of experimental hybridizations which occurred as techniques and knowledge circulated between Stanford biochemists and the Bay Area's experimentalists. Situating their interchange in a dense research network based at Stanford's biochemistry department, this paper helps to revise the canonized history of genetic engineering's origins that emerged during the patenting of Cohen-Boyer's recombinant DNA cloning procedures.
Keywords No keywords specified (fix it)
Categories No categories specified (fix it)
Options
 Save to my reading list
Follow the author(s)
My bibliography
Export citation
Find it on Scholar
Edit this record
Mark as duplicate
Revision history Request removal from index
 
Download options
PhilPapers Archive


Upload a copy of this paper     Check publisher's policy on self-archival     Papers currently archived: 5,875
External links
  • Through your library Configure

    Similar books and articles
    Kenneth F. Schaffner (1994). Interactions Among Theory, Experiment, and Technology in Molecular Biology. PSA: Proceedings of the Biennial Meeting of the Philosophy of Science Association 1994:192 - 205.
    Nicholas Wade (2001). Reporting Recombinant DNA. Perspectives in Biology and Medicine 44 (2):192-198.
    Robert Wake (1982). There Are Few Hazards in Recombinant Dna Research Abstract. In D. R. Oldroyd (ed.), Science and Ethics: Papers Presented at a Symposium Held Under the Aegis of the Australian Academy of Science, University of New South Wales, November 7, 1980. New South Wales University Press.
    M. Richards (2001). How Distinctive is Genetic Information? Studies in History and Philosophy of Science Part C 32 (4):663-687.
    Stephen P. Stich (1978). The Recombinant DNA Debate. Philosophy and Public Affairs 7 (3):187-205.

    Analytics

    Monthly downloads

    Added to index

    2011-05-29

    Total downloads

    2 ( #234,778 of 556,840 )

    Recent downloads (6 months)

    1 ( #64,931 of 556,840 )

    How can I increase my downloads?


    My notes
    Sign in to use this feature


    Discussion
    Start a new thread
    Order:
    There  are no threads in this forum
    Nothing in this forum yet.

    Other forums